56 related articles for article (PubMed ID: 22012422)
1. [Influence of reproductive factors in the clinical and laboratory parameters of rheumatoid arthritis].
Skare TL; Mendes LR
Rev Bras Ginecol Obstet; 2011 Jul; 33(7):132-6. PubMed ID: 22012422
[TBL] [Abstract][Full Text] [Related]
2. Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study.
Karlson EW; Mandl LA; Hankinson SE; Grodstein F
Arthritis Rheum; 2004 Nov; 50(11):3458-67. PubMed ID: 15529351
[TBL] [Abstract][Full Text] [Related]
3. Gynecological/Obstetric Background and Rheumatoid Arthritis: A Cross-sectional Study in Brazilian Patients.
Cavalcante AFDS; Martin P; Skare TL
Rev Bras Ginecol Obstet; 2021 May; 43(5):357-361. PubMed ID: 34077986
[TBL] [Abstract][Full Text] [Related]
4. Female reproductive factors and eye disease in a rural South Indian population: the Aravind Comprehensive Eye Survey.
Nirmalan PK; Katz J; Robin AL; Ramakrishnan R; Krishnadas R; Thulasiraj RD; Tielsch JM
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4273-6. PubMed ID: 15557432
[TBL] [Abstract][Full Text] [Related]
5. Rheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis.
Nikolaisen C; Rekvig OP; Nossent HC
Scand J Rheumatol; 2005; 34(4):269-76. PubMed ID: 16195159
[TBL] [Abstract][Full Text] [Related]
6. Recent onset arthritis in the elderly: a 5 year longitudinal observational study.
Glennås A; Kvien TK; Andrup O; Karstensen B; Munthe E
J Rheumatol; 2000 Jan; 27(1):101-8. PubMed ID: 10648025
[TBL] [Abstract][Full Text] [Related]
7. Influence of number of pregnancies on bone mineral density in postmenopausal women of different age groups.
Gur A; Nas K; Cevik R; Sarac AJ; Ataoglu S; Karakoc M
J Bone Miner Metab; 2003; 21(4):234-41. PubMed ID: 12811629
[TBL] [Abstract][Full Text] [Related]
8. Determining rheumatologists' accuracy at assessing functional disability in rheumatoid arthritis patients using the Health Assessment Questionnaire-Disability Index.
Carter JD; Lodhi AB; Nagda SR; Ricca L; Ward C; Traina E; Thompson ZJ; Huang Y; Valeriano J; Vasey FB
J Rheumatol; 2007 May; 34(5):958-63. PubMed ID: 17407221
[TBL] [Abstract][Full Text] [Related]
9. [A multicenter cross-sectional study on the health related quality of life of patients with rheumatoid arthritis using a revised Japanese version of the arthritis impact measurement scales version 2 (AIMS 2), focusing on the medical care costs and their associative factors].
Hashimoto A; Sato H; Nishibayahi Y; Shiino Y; Kutsuna T; Ishihara Y; Hoshi K; Fujimori J; Tsuboi S; Kondo H; Akizuki M; Moroi Y; Yoshida S
Ryumachi; 2002 Feb; 42(1):23-39. PubMed ID: 11925904
[TBL] [Abstract][Full Text] [Related]
10. Hormonal replacement therapy may reduce the risk for RA in women with early arthritis who carry HLA-DRB1 *01 and/or *04 alleles by protecting against the production of anti-CCP: results from the ESPOIR cohort.
Salliot C; Bombardier C; Saraux A; Combe B; Dougados M
Ann Rheum Dis; 2010 Sep; 69(9):1683-6. PubMed ID: 19740903
[TBL] [Abstract][Full Text] [Related]
11. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
[TBL] [Abstract][Full Text] [Related]
12. Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides.
Pedersen M; Jacobsen S; Klarlund M; Pedersen BV; Wiik A; Wohlfahrt J; Frisch M
Arthritis Res Ther; 2006; 8(4):R133. PubMed ID: 16872514
[TBL] [Abstract][Full Text] [Related]
13. Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis.
Abdel-Nasser AM; Mahmoud MH; El Mansoury TM; Osman AM
Scand J Rheumatol; 2008; 37(5):329-36. PubMed ID: 18666028
[TBL] [Abstract][Full Text] [Related]
14. [Ocular involvement and its' manifestations in rheumatoid arthritis patients].
Markovitz E; Perry ZH; Tsumi E; Abu-Shakra M
Harefuah; 2011 Sep; 150(9):713-8, 751. PubMed ID: 22026055
[TBL] [Abstract][Full Text] [Related]
15. Skin manifestations of rheumatoid arthritis: a study of 215 Turkish patients.
Ergun T; Inanc N; Tuney D; Kotiloglu EK; Seckin D; Tetik C; Direskeneli H
Int J Dermatol; 2008 Sep; 47(9):894-902. PubMed ID: 18937651
[TBL] [Abstract][Full Text] [Related]
16. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
Greiner A; Plischke H; Kellner H; Gruber R
Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
[TBL] [Abstract][Full Text] [Related]
17. Valvular involvement in patients with rheumatoid arthritis.
Beckhauser AP; Vallin L; Burkievcz CJ; Perreto S; Silva MB; Skare TL
Acta Reumatol Port; 2009; 34(1):52-6. PubMed ID: 19449476
[TBL] [Abstract][Full Text] [Related]
18. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
[TBL] [Abstract][Full Text] [Related]
19. Menstrual and reproductive factors and pancreatic cancer in the SEARCH program of the IARC.
Duell EJ; Maisonneuve P; Baghurst PA; Bueno-de-Mesquita HB; Ghadirian P; Miller AB; Zatonski W; Vrieling A; Boffetta P; Boyle P
Cancer Causes Control; 2009 Nov; 20(9):1757-62. PubMed ID: 19653108
[TBL] [Abstract][Full Text] [Related]
20. The role of risk factors for periodontal disease in patients with rheumatoid arthritis.
Gleissner C; Willershausen B; Kaesser U; Bolten WW
Eur J Med Res; 1998 Aug; 3(8):387-92. PubMed ID: 9707521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
